Pharmaceutical Industry Articles & Reports - Page 34

Learn how Retrieval-Augmented Generation (RAG) connects ELN, LIMS, and institutional knowledge for drug discovery. Updated for 2026 with FDA/EMA AI guidelines, Benchling AI agents, GraphRAG, and latest market data.

Learn how machine learning (ML) and AI are transforming pharmaceutical CMC process optimization in 2026. Covers applications, digital twins, regulatory updates (FDA/EMA 2026 AI principles, FRAME initiative), and real-world case studies.

Learn how generative AI and LLMs assist in drafting pharma IND & CTA submissions. This guide covers benefits, risks, GxP compliance, FDA/EMA 2026 joint AI principles, and tools like AutoIND and Narrativa.

Learn to build an AI-powered competitive intelligence stack for biotech in 2026. Covers data sources, NLP/ML methods, generative AI, agentic workflows, EU AI Act compliance, and use cases for R&D strategy.

An educational guide to making your biotech AI-ready. Explore essential data infrastructure fixes for data quality, integration, compute, and governance — updated for 2026 with the latest on pharma supercomputers, FDA/EMA AI guidance, and industry best practices.

An analysis of the 2025 RAM shortage. Learn how massive AI demand for HBM is straining the DRAM supply, leading to surging prices for PC, gaming, and server mem

NVIDIA H100: $25K-$40K. H200: ~$31K ($315K/8-GPU). B200: $30K-$50K. DGX B300 (8-GPU): $300K-$350K. Full 2026 buy vs. cloud rental cost breakdown.

Updated April 2026 guide to Microsoft Copilot pricing ($30/user add-on, $99 E7 Frontier Suite), licensing changes, April 2026 paywall updates, and qualifying Microsoft 365 plans.

An in-depth guide to Mistral Large 3, the open-source MoE LLM. Learn about its architecture, 675B parameters, 256k context window, benchmark performance, and 2026 ecosystem developments including Forge, Small 4, and Voxtral TTS.

Learn how to measure AI ROI in drug discovery beyond cost and time savings. Updated for 2026 with 173+ AI clinical programs, Insilico's Phase IIa results, Recursion-Exscientia merger, and new FDA guidance. Key metrics for scientific outcomes, pipeline productivity, and commercial value.

A framework for biotech CDOs on the build vs. buy AI decision. Analyzes costs, time-to-value, integration challenges, vendor evaluation criteria, and the emerging foundation model licensing trend. Updated April 2026 with EU AI Act compliance deadlines, FDA-EMA joint guidance, and latest pharma AI partnerships.

Updated 2026 guide to AI-assisted SOP drafting in GxP life sciences. Covers FDA CSA final guidance, FDA-EMA GxP-AI Principles, EU AI Act compliance, EMA Annex 22, and validated AI platforms for pharmaceutical quality management.

Explore the ROI of predictive maintenance for lab instruments. Updated for 2026, this guide analyzes ML scheduling cost-benefit factors to reduce downtime and extend equipment life

Learn how AI, LLMs, and agentic AI can build a "Second Brain" for pharma R&D. Updated for 2026 with GraphRAG benchmarks, FDA AI guidance, and enterprise deployment patterns for searchable institutional memory in drug discovery.

Learn how biotech knowledge graphs are built for drug discovery. This guide covers architecture patterns (ETL, ELT, GraphRAG) for integrating compounds, assays, and targets, with 2026 updates on LLM integration and FAIR standards.

Learn how Large Language Models (LLMs) like GPT-5.4 and RAG pipelines are used for financial document analysis. Updated for 2026 with benchmarks, SEC AI disclosure rules, and agentic workflows for extracting insights from SEC filings and corporate decks.

An in-depth guide for bench scientists on using LLM copilots in research. Covers GPT-5.2, Gemini 2.5 Pro, Benchling AI, DeepMind co-scientist, real-world performance data, FDA guidance, and 2026 adoption trends.

Understand algorithmic redlining, a form of AI bias creating housing and lending discrimination. Explore its causes, legal frameworks including the EU AI Act and state enforcement, and effective technical solutions. Updated with 2025-2026 enforcement actions, CFPB changes, and Colorado AI Act developments.

Learn why spreadsheets fail for life sciences contract management. This guide explores how AI-powered CLM platforms — including agentic AI tools like Icertis Vera — improve efficiency, compliance, and clinical trial cycle times. Updated for 2026 with EU AI Act enforcement, FDA/EMA joint AI principles, and the latest Gartner Magic Quadrant CLM leaders.

Compare per-token API costs as of October 2026: Grok 4.7 $2/$6, Gemini 3.8 Flash $0.75/$3.75, GPT-4o $2.50/$10, Claude Sonnet 5.5 $2/$10, plus GPT-6 and Claude Fable tiers and subscription plans.

An educational overview of the NeurIPS 2025 conference. Learn about key trends in AI research, including LLMs, major awards, acceptance rates, and new paper tra

Every Claude plan compared: Free, Pro $20, Max $100-$200, Team, Enterprise, plus per-token API costs for Opus, Sonnet, Haiku. Updated for 2026.

A complete guide to Google Gemini for business plans and pricing (updated April 2026). Learn about Gemini 3.1 Pro, AI Pro/Ultra subscriptions, API costs, Workspace tiers, enterprise models, and real-world use cases.

Oracle's $300B, 5-year cloud deal with OpenAI: 4.5 GW of compute, the live Abilene campus, and Oracle's $664B contract backlog as of August 2026.